Cyclobutane analogs of GABA

Area of Science:

• Neuroscience
• Medicinal Chemistry
• Organic Synthesis

Background:

• Gamma-aminobutyric acid (GABA) is the primary inhibitory neurotransmitter in the mammalian central nervous system.
• Conformationally restricted analogs are valuable tools for probing receptor-ligand interactions and designing novel therapeutics.
• Understanding the structure-activity relationships of GABA analogs can inform the development of drugs targeting neurological disorders.

Purpose of the Study:

• To synthesize cis- and trans-3-aminocyclobutane-1-carboxylic acid as conformationally restricted analogs of GABA.
• To evaluate the GABA-like activity of these analogs in various biochemical and electrophysiological assays.
• To elucidate the impact of conformational restriction on GABAergic signaling.

Main Methods:

• Chemical synthesis of cis- and trans-3-aminocyclobutane-1-carboxylic acid.
• Assays for GABA uptake inhibition in rat brain minislices.
• Measurement of sodium-independent GABA binding to rat brain membranes.
• Evaluation as substrates for GABA aminotransferase.
• In vivo electrophysiological recordings of cat spinal neurons.

Main Results:

• The cis isomer exhibited weak to moderate GABA-like activity across all four tested assays.
• The trans isomer demonstrated significantly less GABA-like activity compared to the cis isomer in all assays.
• Differences in activity are attributed to the conformational "pinning back" of polar groups in the trans analog, leading to steric hindrance at active sites.

Conclusions:

• Conformational restriction of GABA by the cyclobutane ring differentially affects its interaction with GABAergic targets.
• The cis configuration is more conducive to maintaining GABA-like activity, suggesting specific spatial arrangements are critical for receptor binding and enzyme interaction.
• The trans isomer's reduced efficacy highlights the importance of steric factors in the pharmacophore of GABA analogs.